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The application of immunologic advances regarding B cell activation to the 
understanding of the human IgE antibody response has been hampered by the 
lack of reproducible in vitro models for the induction of IgE synthesis (1-3). 
Recently, Lanzavecchia (4)  has reported that human alloreactive T  cell  clones 
can  induce  IgE  secretion  by  human  B  cells.  However,  their  study  did  not 
characterize the allergic status of the B cell donors. B cells from allergic donors 
differ from normal B cells  in that they spontaneously secrete IgE (1-3,  5,  6). 
Because of this, B cells  from allergic vs. normal subjects are likely to differ in 
their requirements for the induction of IgE synthesis in vitro. The delineation 
of these  differences has  important implications for the  understanding of the 
human allergic response. 
In the present study we report that an alloreactive T  cell clone can induce IgE 
synthesis in B cells from both allergic and nonallergic individuals. It was found 
that induction of IgE synthesis in B cells from nonallergic donors occurred only 
under  conditions  of cognate  interaction  with  T  cells,  in  which  the  B  cells 
expressed the alloantigen recognized by the T  cells. In contrast, IgE synthesis in 
B cells from allergic donors did not necessarily require direct interaction with T 
cells.  It occurred under conditions of cognate interaction with T  cells as well as 
under bystander conditions in which the B cells did not express the alloantigen 
recognized by the T  cell clones. These differential requirements for induction 
of  IgE  synthesis  in  B  cells  from  normals  and  allergic  subjects  may  reflect 
differences in the state of activation of in vivo circulating IgE B cells  in these 
donors. 
Materials and Methods 
B Cell Donors.  Six healthy adult nonallergic subjects were selected on the basis of a 
negative  history  for allergies  and on  the  basis of a  serum  IgE  level <75  IU/ml  (as 
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determined by a  PRIST assay;  Pharmacia, Inc., Uppsala, Sweden).  Three adult allergic 
subjects wit h positive histories of allergic disease  (e.g.,  seasonal  allergic rhinitis,  extrinsic 
asthma, and eczema) and with elevated serum IgE levels (>400 IU/ml) were also studied. 
Written  consent  was  obtained  from  all  subjects  before  the  study.  Peripheral  blood 
mononuclear cells (PBMC) ~ from donors were HLA-DR typed in a standard microcyto- 
toxicity assay by the Histocompatibility Lab at the Dana Farber Cancer Institute, Boston. 
Isolation  of Mononuclear  Cell Subpopulations.  PBMC were isolated from the blood of 
healthy donors by flotation over Ficoll-Hypaque, and washed three  times with  Hanks' 
balanced salt solution. 
B Cells.  T  cells were depleted from PBMC by rosette formation with aminoethyliso- 
thioronium (AET)-treated sheep cells. E rosette-negative cells were enriched by flotation 
over FicolI-Hypaque. In some experiments, E rosette-negative cells were further purified 
by treatment  with  OKT3  (Ortho  Pharmaceutical,  Raritan,  NJ)  and  complement (Pel- 
Freeze Biologicals,  Rogers, AR) to remove residual T  cells. 
Preparation  of Monocytes.  PBMC were incubated overnight in petri dishes  at 37°C in 
media containing 10% AB+ serum. In some experiments the PBMC were pulsed overnight 
with tetanus toxoid, 50 #g/ml. Nonadherent cells were then removed, and the remaining 
adherent cells were washed with warm media.  Ice-cold phosphate-buffered saline  (PBS) 
was added to the dishes,  and the monocytes were aspirated and resuspended in  RPMI 
1640. Monocytes were irradiated (2,500 rad) before being added to 96-weU plates (2 x 
104 cells per well). 
Preparation  of T Cell Clones.  T  lymphocyte clones with specificity  for tetanus toxoid 
(TT) and/or alloantigens were produced as  previously described (7). Two clones were 
used. Clone F6 is a TT-specific clone that is restricted by HLA-DR3 and shows limited 
alloreactivity (7). G8 is a  TT-specific clone restricted by HLA-DR5. These clones were 
derived from an HLA-DR3,5 donor as follows.  10 x  106 PBMC were suspended in 10 ml 
RPMI 1640 (M. A. Bioproducts, Walkersville,  MD) containing 10% AB+ serum (complete 
medium) and stimulated with TT at 30 #g/ml. After incubation at 37°C in 5% CO2 for 
6 or 7 d, the cultures were harvested and dividing cells were enriched by centrifugation 
over a Percoll (Pharmacia, Inc.) discontinuous gradient at 1,500 rpm for 45 min. Cells at 
the 30-50% interface were resuspended in  complete medium supplemented  with  25% 
interleukin  2-containing supernatants  (IL-2 SN)  that  contained irradiated  (2,500  rad) 
autologous  PBMC  plus  TT  and  were  distributed  in  96-well  trays  (Nunc,  Roskilde, 
Denmark). Each 0.2 ml well contained an average of 0.3 blast and 105 irradiated PBMC. 
After 14-21  d of culture, cells were transferred to 24-well  trays (Linbro Scientific  Co., 
Hamden, CT). Clones have been maintained in culture for > 1 yr with repeated stimulation 
with antigen  (TT and autologous PBMC) and  IL-2 SN.  T  cell  clones were extensively 
subcloned by limiting dilution at 0.3 cell per well. 
IL-2 SN.  PBMC were obtained from donors previously screened for their capacity to 
generate high activity IL-2. PBMC were depleted of monocytes by adherence to plastic 
petri dishes and the nonadherent cells were irradiated (1,000 rad). Cells were suspended 
at 106 cells/ml in RPMI 1640 with 2% AB+ serum containing phytohemagglutinin (1 ~g/ 
ml; Burroughs Wellcome Co., Research Triangle Park, NC), and harvested after 48 h. 
Immunoglobulin  Synthesis in Cell Cultures.  The cell culture system used for the induc- 
tion of immunoglobulin synthesis was performed in 96-well  microtiter plates,  in  RPMI 
1640 medium containing 10% fetal calf serum in a humidified atmosphere of 5% CO2 in 
air. Each microtiter well contained the following: (a) E rosette-negative cells (B cells),  I 
x  105/well; (b) irradiated (2,500 rad) monocytes (to activate the T  cell clones),  2 x  104/ 
well; (c) irradiated (2,500 rad) cloned T  cells, 4 x  104/well,  when indicated. After 96 h 
of culture the cells were washed twice with culture medium. This washing step was done 
to remove IgE released in the first 4 d of culture. Fresh medium was added, and cultures 
were incubated for an additional 8 d in the presence or absence of the protein synthesis 
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inhibitor  cycloheximide (100  ug/ml).  SN  were  harvested  from  duplicate  cultures  and 
assayed for immunoglobulin (IgE, IgG, IgA, IgM) content. 
Acid Treatment of Cultured Cells.  To determine the amount of IgE associated with the 
cells, we acid-treated the cells at days 0 and 4 after washing,  as described by Turner et al. 
(8). 5 ×  105 E rosette-negative B cells with 105 irradiated adherent cells were pelleted in 
5-ml tubes. The cells were resuspended in 0.4 ml of 0.01  M glycine buffer, pH 2, for 1 
min.  0.6  ml of 0.15  M  PBS,  pH  7.4, was added to obtain a  final  pH of 7 and a  final 
volume of 1 ml. The SN were then collected and assayed for IgE. 
Radioimmunoassay (RIA)for IgE.  Duplicate samples  from each culture were analyzed 
for their IgE content. The RIA for IgE was performed in flexible  flat-bottom microtiter 
plates (Becton, Dickinson & Co., Oxnard, CA). The wells were filled with 0.1  ml of a  10 
t~g/ml solution containing a  1:1 mixture of two monoclonal anti-human IgE, Fc-specific 
antibodies (monoclonal antibodies 8 and 9). After incubation for 16 h, the coating solution 
was removed, and the wells were washed and blocked with 10% horse serum (HS) in PBS 
for 2  h.  After washing three  times  with  PBS  containing  1%  HS,  we  added  0.1  ml  of 
culture SN or of IgE standard to each of the triplicate wells and incubated them for 16 h 
in a humidified chamber at room temperature.  The wells were then washed twice  with 
PBS,  1% HS containing 0.5% Tween 20 and twice with PBS,  1% HS alone; then 0.1  ml 
of Phadebas RAST ~SI-anti-human IgE (ND) (Pharmacia,  Inc.; sp act,  12 #Ci/t~g) was 
added to each well. 6 h later the radiolabeled anti-IgE was removed and wells were washed 
three times with PBS,  1%  HS and eight times under running distilled  water. The wells 
were cut out and counted in a gamma spectrometer (TM Analytic, Inc., Elk Grove, IL). 
Standard curves were constructed using dilutions of the  IgE standards  obtained from 
Pharmacia, Inc. The concentration of IgE in the SN was read from the standard curve. 
Results were expressed as  the  mean of duplicate  determinations  of duplicate cultures. 
The lower limit of sensitivity  of this assay was 100-200 pg/ml. 
The specificity  and sensitivity  of our IgE RIA was confirmed in a recently completed 
multi-institutional  study coordinated  by the  Mayo  Clinic  (Drs.  Yunginger,  Helm  and 
Gleich; manuscript in preparation).  Coded samples  with varying quantities of polyclonal 
IgE  in  the  presence  of other  immunoglobulin  isotypes  sent  to  our  laboratory  were 
evaluated  using our  IgE RIA.  In no test  sample  did  we  measure  falsely  elevated  IgE 
values,  thus ruling out the possibility  of crossreactivity with other isotypes.  Furthermore, 
values of IgE >300 pg/ml were measured accurately within 10% of expected values. 
Enzyme-linked lmmunosorbent Assays (ELISA) of SN for IgG, IgA,  and  lgM.  96-well 
polystyrene plates were coated with immunoabsorbed, purified goat anti-IgG, anti-IgA, 
or anti-IgM (Tago,  Inc.,  Burlingame,  CA) (10 /tg/ml).  After washing with  PBS,  0.1% 
Tween 20,  the plates were incubated with a  0.1% gelatin solution for 1 h and washed, 
and 0.1  ml of appropriately diluted SN were added to the wells. After  18 h  the plates 
were again washed, and horseradish peroxidase-conjugated anti-IgG, -IgA, or -IgM was 
added (1:3000). The plates were incubated for 1 h at 37 °C and washed, and the bound, 
tagged antibody was quantitated using the substrate, azino-diethyl-benzthiazoline sulfonic 
acid. Plates  were incubated with the substrate for 30 min, and the absorbance at 414 nm 
was read on a Titertek Multiskan Spectrophotometer (Flow Laboratories, Inc., McLean, 
VA). Standard curves were performed using purified Ig (Kallestad  Laboratories, Austin, 
TX).  The  specificity  of the  conjugated antisera  was ascertained  by testing in  a  direct 
ELISA against  purified  human  myeloma G,M,A  and  kappa  and  lamda  Bence Jones 
proteins. 
Results 
Induction of IgE Synthesis by Alloreactive  T  Cell Clones.  The characteristics of 
the T  cell clones used in this study are shown in Table I. Both clones were T4  +. 
Clone F6 exhibited  both alloreactivity and reactivity to TT  antigen  (described 
in  detail  in  reference  7).  The  alloreactivity  of  F6  is  preferentially  but  not 
exclusively directed to HLA-DR4  + cells.  F6 proliferated in response to stimula- 
tion  with  13  of  14  HLA-DR4  ÷ cells  and  3  of 18  of HLA-DR4- cells.  F6  also UMETSU  ET  AL.  205 
TABLE  I 
Characteristics of T Cell Clones 
Surface 
Clone  pheno-  Alloreactivity  Antigen specificity 
type 
F6  T4 +  HLA-DR4 and others  TT and HLA-DR3 
G8  T4 +  None  TT and HLA-DR5 
TABLE  II 
Characteristics of B Cell Donors 
Capacity 
Donors  Atopic disease  Serum IgE  HLA-DR  to stimu- 
late F6 
IU/ml 
Allergic subjects 
KR  A.R., asthma, eczema  2,000  3, 5  - 
DU  A.R., eczema  1,200  9, -  + 
DY  A.R., asthma  488  3, 4  + 
Nonallergic subjects 
MS  --  72  1, 7  + 
RG  --  63  5, 6  - 
NW  --  50  3, -  - 
DE  --  36  3, 4  + 
RF  --  10  1, 2  - 
SY  --  <4  3, 4  + 
The capacity of x-irradiated (2,500 tad) PBMC to stimulate the proliferation of clone F6 over a 4 d 
culture period was studied. Stimulation indices were calculated by dividing counts per minute (cpm) 
of [~H]thymidine incorporated in these cultures by the cpm of [SH]thymidine incorporated in cultures 
where F6 was stimulated with autologous irradiated PBMC  obtained from donor F6.  Irradiated 
PBMC from DU, DY, MS, DL, and SY, respectively, caused a 81, 89, 35, 80, and 84-fold stimulation 
of F6 cells.  PBMC  from all other donors caused less than twofold stimulation of F6 cells.  A.R., 
allergic rhinitis. 
proliferated to TT  presented  by HLA-DR3 + accessory cells. Clone G8 is a  TT- 
specific  clone  that  exhibited  no  alloreactivity against  a  panel  of  10  randomly 
chosen donors. G8 proliferated to TT  presented  by HLA-DR5 + cells (7). 
The  characteristics of the  nine  adult donors  whose  B  cells were  used in  this 
study are shown  in Table  II. These  characteristics include allergic status, serum 
IgE, HLA-DR  phenotype,  and their cells' ability to stimulate F6. 
Table  III depicts an  experiment  in  which  the ailoreactive clone  F6 was  used 
to induce Ig synthesis in B  cells obtained  from two donors, one allergic and one 
nonallergic. Cells from both donors were known to be capable of stimulating the 
F6  proliferation.  In  the  presence  of irradiated, cloned  F6  cells, polyclonal  Ig, 
including  IgE,  synthesis  was  induced  in  B  cells  of  both  donors  (Table  III). 
Spontaneous  IgE synthesis could be detected only in cultures of B  cells from the 
allergic  and  not  the  nonallergic  subject.  Pokeweed  mitogen  (PWM)  (Sigma 
Chemical Co., St. Louis, MO), in the presence of added autologous T  cells, failed 
to  induce  IgE  synthesis  in  B  cell  cultures  of both  subjects  in  spite  of PWM's 
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TABLE  III 
Induction of Antibody Synthesis by AUoreactive T Cell Clone F6 
B cell donor  Ig produced 
Donor  Allergic status  Stimulus  IgG  IgM  IgA  IgE 
DL  Nonallergic 
DU  Allergic 
ng/ml  ng/ml  ng/ml  pg/ml 
--  200  200  90  <150 
F6  6,250  8,000  543  2,530 
PWM  4,440  10,800  3,150  <150 
--  200  200  90  670 
F6  39,000  20,250  840  4,657 
PWM  4,760  3,200  1,380  <150 
All cultures contained 105 E rosette-negative cells (B cells). Cultures stimulated with F6 received 4 
x  104 irradiated (2,500 rad) F6 cells. Cultures stimulated with PWM received autologous T  cells (T/ 
B ratio, 2:1) and 1 t*g/ml of PWM. All cultures were washed on day 4 and SN were collected from 
day  4  to  day  12  and  assayed  for  Ig  content.  The  results  represent  the  mean  of duplicate  Ig 
determinations of duplicate cultures. Similar results were obtained in four other experiments. 
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FIGURE  1.  IgE associated with the cell pellet as determined by acid elution from the cell 
pellets. IgE associated with the cell pellet on day 0  was released into the culture supernatant 
by day 4 of culture. (*) Undetectable. 
Calculation  oflgE Synthesis.  In  the present experiments we have minimized 
the contribution of preformed IgE to our measurement of IgE synthesis. Cultures 
were washed on day 4  to remove IgE released into the SN  in  the first 4  d  in 
culture.  Acid elution of the cell pellets at days 0 and 4  showed that,  by day 4, 
IgE associated with the cell pellet had become undetectable (Fig.  1) presumably 
because it  was released  into  the  culture  supernatant.  The  day-4  washed  cells 
were then incubated for eight more days in the presence or absence of cyclohex- 
imide. Fig. 2 shows that cycloheximide-treated cultures contained no detectable 
IgE. In subsequent tables results are presented as net IgE synthesis, obtained by 
subtracting IgE values of cell pellets at day 4 from IgE values in SN of day 4-12 
cultures. 
Induction  of lgE Synthesis by T Cell Clones in B Cells Under Conditions of Cognate 
and Noncognate Interaction.  We next asked if induction  of IgE synthesis in  B 
cells by the alloreactive clone F6 could proceed under conditions of noncognate 
interaction as well as under conditions of cognate interaction.  Under conditions UMETSU  ET  AL.  207 
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FIGURE 2.  IgE values of cultures using B cells from a  nonallergic donor (top) and B cells 
from an allergic donor (bottom). Net IgE synthesis in stimulated cultures for tables was derived 
by subtracting IgE associated with cell  pellet on  day  4  from total  IgE  in  supernatants of 
stimulated cultures. 
TABLE  IV 
Alloreactive Clone F6 Induces B Cells  from Allergic Subjects to 
Secrete IgE Under Conditions of Cognate and Noncognate Interaction 
Donor of  B-T cell interaction  Clone F6  B cells 
Ig produced 
IgE  IgG 
Cognate 
pg/ml  ng/mt 
DU  -  600  75 
+  9,600  10,000 
DY  -  355  50 
+  1,465  4,250 
Noncognate  KR  -  695  62 
+  1,490  1,963 
Cultures  contained  10 s  E  rosette-negative cells  (B  cells),  and,  where 
indicated,  4  x  104  irradiated  F6  cells.  Under  conditions of cognate 
interaction, 2  X  104 additional irradiated monocytes from the donor of 
the  B  cells  were  added  to  cultures.  Under  conditions of noncognate 
interaction, 2 ×  104 irradiated monocytes from third-party donors whose 
cells stimulated F6 were added. All B cell donors had serum IgE levels 
>400 IU/m[. 
of cognate interaction the B cells expressed alloantigens recognized by F6 as was 
seen in Table III. Under conditions of noncognate interaction, the B cells lacked 
these alloantigens, and irradiated third-party monocytes known to be allostimu- 
lators of F6  were added  to the cultures. Table IV depicts the results obtained 
with B cells from allergic subjects stimulated by F6 under cognate or noncognate 
conditions. IgE synthesis was induced in these cells under conditions of cognate 
interaction as well as noncognate interaction in which B cells were bystanders. 
Similar findings were observed for the induction of IgG synthesis. 
Table V  shows that,  in contrast to B cells from allergic donors, B cells from 
normal donors were induced to synthesize IgE only under conditions of cognate 
interaction with F6 (donors DL, MS, SY). Bystander normal B cells that did not 208  INDUCTION OF  IgE SYNTHESIS  BY  AN  ALLOREACTIVE T  CELL  CLONE 
express alloantigens capable of stimulating F6 synthesized no IgE in the presence 
of F6 and third-party allostimulator monocytes (Table V, donors RG, RF, NW). 
In the same cultures, the normal bystander B cells from these three donors were 
induced to synthesize IgG. Thus,  the failure of normal B cells to synthesize IgE 
under conditions of noncognate interaction was IgE isotype specific and was not 
due to lack of activation of F6.  Failure of bystander normal B cells to synthesize 
IgE  occurred  even  when  the  donor  of  B  cells  shared  a  common  HLA-DR 
determinant (HLA-DR3 or HLA-DR5) with the donor of the T  cell clone. Thus, 
mere  sharing  of HLA-DR  determinants  by  the  clone  and  by  B  cells  was  not 
sufficient to activate the B cells into IgE synthesis. 
The induction  of IgE in bystander B  cells from allergic donors but not from 
normal  donors  was  not  restricted  to  alloreactive  clones.  Table  VI  shows  that 
similar data was obtained when B cells were cultured with irradiated T  cells from 
the TT-specific clone G8 in the presence of TT-pulsed, HLA-DR5 ÷ third-party 
monocytes known to activate G8. IgE synthesis in these cultures was induced in 
B cells from allergic donors, but not in B cells from nonallergic donors, whereas 
IgG synthesis was induced in B cells from all donors. 
Role of Residual T Cells on Induction of lgE Synthesis  in B Cells.  The induction 
of IgE synthesis  in  B  cell  cultures  by cloned T  cells was unlikely to  have been 
mediated by residual T  cells that contaminated the B cell-enriched populations. 
B cell-enriched populations from allergic subjects vigorously depleted of residual 
T  cells  by  treatment  with  OKT3  and  complement  (Table  VII)  synthesized 
equivalent amounts of IgE as non OKT3 plus C'-treated B cell populations when 
stimulated with cloned T  cells. This was regardless of whether the stimulus was 
delivered by cognate or noncognate bystander interaction. 
Role of Antigen  Recognition  by T  Cells  in B  Cell Activation.  It is important  to 
TABLE  V 
Clone F6 Induces B CeUs  from NonaUergic Donors to Secrete IgE 
Only Under Conditions of Cognate Alloreactive Recognition 
Source of  Clone  B-T cell interaction  B cells  F6 
Ig produced 
IgE  IgG 
Cognate 
pg/ml  ng/ml 
DL  -  <150  1 I0 
+  8,000  10,000 
MS  -  200  170 
+  7,970  5,000 
SY  -  <150  400 
+  925  33,000 
Noncognate  RG  -  < 150  20 
+  <150  5,100 
RF  -  <150  20 
+  <150  1,475 
NW  -  <150  75 
+  <150  6,000 
Culture  conditions are similar to those described in Table IV. All B cell 
donors had serum IgE levels <75 IU/ml. UMETSU  ET  AL. 
TABLE  VI 
Failure of an Antigen-specific T Cell Clone G8 to Induce IgE 
Secretion  from Nonallergic Subjects 
Source of B cells  Clone G8 
lg produced 
IgE  IgG 
Allergic Donors 
DU 
KR 
pg/ml  ng/ml 
-  1,350  120 
+  12,380  2,000 
-  700  225 
+  6,275  2,400 
Nonallergic Donors 
NW  -  187  140 
+  <150  3,000 
MS  -  <150  250 
+  225  3,500 
RG  -  <150  20 
+  <150  1,250 
DL  -  <150  44 
+  <150  1,335 
All cultures contained  105 E rosette-negative cells (B cells), and, where 
indicated, 4 ×  104 irradiated G8 cells. Third-party HLA-DR5 ÷, TT-pulsed 
monocytes  (irradiated  with  2,500  rad)  were  added  to  all  cultures  to 
stimulate GS. 
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TABLE  VII 
Effect of Residual  T Cells on Induction of lgE Synthesis in B Cell Cultures by T Cell Clones 
Stimulat-  OKT3 
Type of B-T interaction  B cell donor  ing clone  plus C'  IgE  IgG 
Cognate  Allergic 
Noncognate (bystander)  Allergic 
pg/ml  ng/ml 
--  -  235  184 
--  +  500  90 
F6  -  4,600  62,500 
F6  +  4,450  75,000 
--  -  280  230 
--  +  450  100 
G8  -  1,500  2,250 
G8  +  2,080  3,350 
Culture conditions are similar to those described in Table IV. E rosette-negative cells were incubated 
with OKT3 at 0°C as indicated. After 40 rain at 0°C, baby rabbit complement was added. After 30 
min incubation at 37°C, the cells were washed and then placed in culture (1 ×  105/well). Clone F6 
was stimulated by alloantigens expressed by the B cell donor. Clone G8 was stimulated by the addition 
of HLA-DR5 +, TT-pulsed monocytes. 
emphasize  that,  in  the  absence  of  T  cell  recognition  of  antigen,  no  activation 
signal  was  delivered  to  the  B  cells.  When  B  cells  from  a  normal  subject  whose 
cells did  not  stimulate  clone  F6 proliferation  were  cultured  with F6 (Table  VIII), 
neither  IgE nor  IgG  was secreted.  Only  when  HLA-DR4  + third-party  monocytes 
were  added  to the culture  were  the  normal  B  cells stimulated  to secrete  IgG,  but 210 INDUCTION  OF  IgE  SYNTHESIS  BY  AN  ALLOREACTIVE  T  CELL  CLONE 
TABLE  VIII 
Antigen Recognition by Cloned T Cells Is Required  for the Induction 
of lg Synthesis Under Conditions of Noncognate Bystander Interaction 
Third- 
Source of bystander  party 
stimula-  Clone  B cells 
tot  I~/lon - 
ocytes 
Ig produced 
IgE  IgG 
pg/ml  ng/ml 
Nonallergic  +  F6  < 150  1,500 
-  F6  <150  20 
Allergic  +  G8  1,105  1,300 
-  G8  <150  55 
Culture conditions are similar to those described in Table IV. HLA-DR5 +, 
TT-pulsed monocytes (2,500 rad irradiated) functioned as stimulator cells 
for G8. HLA-DR4 ÷ monocytes (2,500 rad irradiated) functioned as stim- 
ulator ceils for F6. 
not IgE, via a bystander interaction. When B cells from an allergic subject were 
cultured with clone G8, neither IgG nor IgE synthesis was induced unless TT- 
pulsed HEA-DR5 + monocytes were added to activate clone G8. 
Discussion 
The present study demonstrates that de novo IgE synthesis can be induced in 
B cells of allergic as well as normal subjects under conditions of cognate inter- 
action by an alloreactive clone. Furthermore, B cells from allergic but not from 
normal donors synthesized IgE when present as bystanders in cultures containing 
alloactivated or antigen-activated cloned T  cells. 
Until  recently,  the  study  of human  IgE  synthesis  has  been  limited  to  the 
spontaneous IgE secretion by B cells from allergic individuals (1-3, 5, 6). In our 
hands and those of several other investigators (1, 2), polyclonal B cell activators, 
such as PWM, have failed to induce IgE synthesis in peripheral blood B cells of 
both normal and allergic donors. The unique ability of T  cell clones to induce 
IgE synthesis in B cells from normal donors may relate to several observations. 
First,  these clones are more powerful polyclonal activators than PWM  in that 
they cause better production of IgG and IgM (Table III) and activate a  higher 
frequency of B cells (4). Second, T  cell clones activate both small as well as large 
B  cells  (9,  10)  whereas PWM  appears  to  activate only large  B  cells  that  are 
thought to represent B cells preactivated in vivo.  Finally, helper T  cell clones 
provide helper activity for Ig synthesis in the absence of suppressor T  cells. In 
murine systems, interactions of unfractionated T  cells with  aliogeneic B  cells 
have been reported to induce IgG synthesis and suppress IgE synthesis (1 1). It is 
likely that IgE synthesis is uniquely sensitive to suppressor signals generated by 
unfractionated T  cells responding in a mixed lymphocyte reaction. The differ- 
ential sensitivity of the IgE vs. IgG antibody response to suppressor signals has 
been well documented (12). 
Although, in the present study, we used a single alloreactive T  cell clone, F6, UMETSU ET AL.  211 
to induce IgE synthesis, this phenomenon is  not limited to clone F6.  Indeed, 
Lanzavecchia (4) observed this phenomenon with several alloreactive clones. The 
successful induction of IgE synthesis in normal nonailergic subjects under con- 
ditions of cognate interaction with T  cell clones demonstrates the presence of 
circulating B cells with the potential to differentiate into  IgE-secreting cells in 
normal individuals.  It is not known whether the T  cell clones activate B cells 
already committed to  express  IgE and/or cause switching of some B  cells  to 
synthesize IgE. In this regard, Mayer et al. (13) have recently presented evidence 
on the ability of monoclonai human leukemic T  cells to cause an IgM to IgG 
switch in B cells of patients with the hyper IgM syndrome. 
Perhaps the most important finding of the present study is the demonstration 
of a basic difference between allergic and nonallergic subjects in the IgE response 
of their B cells under conditions of bystander stimulation by T  cell clones. The 
data demonstrate that normal B cells can be activated only under conditions of 
cognate interaction by the T  cell clones (Table IV). Normal B cells that lacked 
the stimulatory alloantigens made no IgE in the presence of alloreactive T  cells 
stimulated by third-party monocytes bearing the appropriate alloantigens. This 
observation makes it likely that the induction of IgE synthesis in normal B cells 
bearing the stimulating alloantigens actually involves direct recognition of these 
antigens by the T  cell on the B cell surface, rather than bystander activation 
resulting from recognition of the alloantigens on the surface of monocytes in the 
B cell-enriched populations.  Thus, direct T-B cell interaction via T  cell recog- 
nition of B cell surface alloantigen appears to be required for IgE induction in 
normal B ceils. 
Recently, Nutman et al. (14), using filariai parasite-specific T cell lines or their 
SN, were able to induce IgE synthesis in  B cells from nonatopic B cells. They 
found, however, that SN from helper T  cell lines raised against a  nonparasite 
antigen  did  not  induce  IgE  production,  perhaps  indicating  that  the  parasite 
antigen  was  critical  for  the  induction  of IgE  synthesis  in  their  system.  The 
antigen-specific clone used in our study (clone G8) was directed against TT, a 
nonparasite antigen. Neither this nor other TT-specific clones (data not shown) 
induced IgE synthesis in normal B cells. 
In contrast to the requirement for cognate interaction for the induction of 
IgE synthesis in normal B cells, induction of IgG synthesis in the same B cells 
occurred both under conditions of cognate interaction and bystander activation. 
Our finding that T  cell clones provide major histocompatibility complex-unre- 
stricted help for IgG synthesis by human B cells confirms and extends the reports 
of others  (4,  15).  The  reason  for  the  differential  response  of IgG  and  IgE 
synthesis to bystander stimulation of normal B cells may relate to the in  vivo 
activation status of B cells committed, respectively, to IgG and IgE synthesis in 
normal subjects. The lack of spontaneous IgE synthesis by normal circulating B 
cells suggests that few if any IgE B cells circulate in an activated state in normal 
nonallergic subjects. On the other hand, B cells from normal individuals spon- 
taneously  produce  IgG.  The  majority  of the  in  vivo  activated  B  cells  that 
spontaneously secrete IgG have been shown to reside in the less dense fractions 
of a density gradient, to be large, and to respond to T  cell-dependent, PWM- 
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In  contrast  to  normal  B  cells,  B  cells  from allergic  subjects  responded  to 
bystander stimulation by synthesizing IgE (Table IV). This response is consistent 
with the presence in these individuals of circulating, activated IgE B cells that 
synthesize IgE spontaneously. These secreting IgE cells were recently shown (18) 
to be relatively large and to respond to T  cell-derived, IgE-binding factors by 
enhancing their IgE synthesis. 
Several  mechanisms  may  underlie  the  bystander  activation  of  B  cells  by 
alloreactive and antigen-specific T  cell clones. It is possible that B cells activated 
in vivo are selectively capable of capturing shed alloantigens or the immunogenic 
complex of TT plus HLA-DR, and of presenting these antigens to T  cells.  This 
would  result  in  direct  T-B  cell  interaction  and  subsequent  induction  of Ig 
synthesis,  and  would  account  for  the  selective  induction  of IgE  synthesis  in 
bystander B cells from allergic donors, since only those donors possess activated 
B cells that are committed to IgE synthesis. An alternative explanation for the 
bystander effect would involve the action of soluble mediators derived from the 
T  cell clones. SN of activated T  cell clones have been shown (17) to contain a 
variety of factors, including B  cell growth and differentiation factors (BCGF, 
BCDF), interleukin 2,  and IFN, that enhance expansion and differentiation of 
partially activated B cells.  Furthermore, IgE-binding factors that enhance IgE 
synthesis (19,  20) can be released by T  cells bearing Fc receptors for IgE.  All 
these  factors,  including  IgE-binding  factors,  appear  to  exert  their  action  on 
preactivated B cells rather than on resting B cells (19).  Indeed, resting B cells 
either do not express enough receptors for these factors and/or do not respond 
to  them.  Experiments are currently underway to  determine whether the  by- 
stander effect can be mediated by SN of activated T  cells clones. 
The results of the present investigation have important implications for the 
study of the human IgE response. Induction of IgE synthesis by alloreactive T 
cells  may underlie  the  rise  in  IgE  serum  in  acute  graft-vs.-host disease  (21). 
Bystander activation of B cells into IgE synthesis by antigen-reactive T  cells may 
play a role in the polyclonal IgE response in viral and parasitic infections. Finally, 
T  cell clones should provide a useful tool for detailed study of the regulation of 
the human IgE response in health and disease. 
Summary 
Human T  cell helper/inducer clones were used to induce IgE synthesis in B 
cells from both  allergic and  nonallergic donors.  An alloreactive T  cell clone, 
activated  by  recognition  of specific  HLA-DR  antigens,  stimulated  peripheral 
blood  B  cells  from  both  allergic  and  nonallergic  donors  to  synthesize  IgE 
antibody. B cells of allergic donors differed from those of nonallergic donors in 
their requirements for induction of IgE synthesis. Induction of IgE synthesis in 
B cells from nonallergic individuals occurred only under conditions of cognate 
interaction, in which the B cells expressed the alloantigen recognized by the T 
cells. In contrast, IgE synthesis in B cells from allergic donors occurred under 
conditions of cognate interaction with T  cells as well as bystander conditions 
where the B cells did not express the alloantigen recognized by the T  cell clones 
and where the T  cell clones were stimulated by third-party monocytes bearing 
the relevant alloantigens.  Furthermore, bystander stimulation of IgE synthesis UMETSU  ET  AL.  213 
in  allergic  donors  occurred  in  the  presence  of tetanus  toxoid  (TT)  antigen- 
specific T  cell clones activated by the appropriate TT-pulsed monocytes. 
In contrast to the differing requirements of B  cells from normal  vs. allergic 
subjects for the induction of IgE synthesis, these B  cells did not differ in their 
requirements for the induction of IgG synthesis. IgG synthesis was induced in all 
B cells under conditions of cognate interaction with the T  cells as well as under 
conditions of bystander stimulation. These results suggest that cognate T-B cell 
interactions may be important in the development of IgE immune responses in 
the normal host. 
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